IMS Health Announces Launch of Secondary Public Offering Of Common Stock
August 05 2015 - 3:35PM
Business Wire
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) today
announced the launch of an underwritten, secondary public offering
of 20,000,000 shares of its common stock by certain of its existing
shareholders affiliated with TPG Global, LLC, Canada Pension Plan
Investment Board and Leonard Green & Partners, L.P. (the
“Selling Shareholders”). IMS Health is not offering any stock in
this transaction and will not receive any proceeds from the sale of
the shares by the Selling Shareholders.
J.P. Morgan and Morgan Stanley are acting as the joint
book-running managers.
An automatic shelf registration statement (including a
prospectus) relating to the offering of common stock was filed with
the Securities and Exchange Commission (“SEC”) on May 4, 2015 and
became effective upon filing. Before you invest, you should read
the registration statement, prospectus and other documents IMS
Health has made available with the SEC for information about IMS
Health and the offering. You may obtain these documents free of
charge by visiting EDGAR on the SEC website at www.sec.gov.
Alternatively, copies of the prospectus and accompanying prospectus
supplement, when available, may be obtained from: J.P. Morgan
Securities LLC, c/o Broadridge Financial Solutions, 1155 Long
Island Avenue, Edgewood, NY 11717, or by telephone at (866)
803-9204; or Morgan Stanley & Co. LLC, Attention: Prospectus
Department, 180 Varick Street, 2nd Floor, New York, NY 10014.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or other jurisdiction
in which such an offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of
any such state or other jurisdiction.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
comprehensive solutions to measure and improve their performance.
End-to-end proprietary applications and configurable solutions
connect 10+ petabytes of complex healthcare data through the IMS
OneTM cloud platform, providing comprehensive insights into
diseases, treatments, costs and outcomes. The company’s 15,000
employees blend global consistency and local market knowledge
across 100 countries to help clients run their operations more
efficiently. Customers include pharmaceutical, consumer health and
medical device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such forward-looking statements include those regarding
the proposed secondary offering by the Selling Stockholders and
reflect, among other things, our current expectations and
anticipated results of operations, all of which are subject to
known and unknown risks and uncertainties, including market
conditions, local, regional, national and international economic
conditions, and regulatory, competitive and other factors, which
may cause actual financial or operating results or the timing of
events to be materially different than those expressed or implied
by forward-looking statements. Forward-looking statements are not
guarantees that the future results, plans, intentions or
expectations expressed or implied will be achieved. Therefore, any
statements contained herein that are not statements of historical
fact may be forward-looking statements and should be evaluated as
such. The words “guidance,” “ongoing,” “believes,” “expects,”
“may,” “will” and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. Important factors that
could cause or contribute to such differences include, but are not
limited to: imposition of restrictions on our use of data by data
suppliers or their refusal to license data to us; failure to meet
our productivity objectives; failure to successfully invest in
growth opportunities; imposition of restrictions on our current and
future activities under data protection and privacy laws; breaches
or misuse of our or our outsourcing partners’ security or
communications systems; hardware and software failures, delays in
the operation of our computer and communications systems or the
failure to implement system enhancements; consolidation in the
industries in which our clients operate; our ability to protect our
intellectual property rights and our susceptibility to claims by
others that we are infringing on their intellectual property
rights; the risks associated with operating on a global basis,
including fluctuations in the value of foreign currencies relative
to the U.S. dollar, and the ability to successfully hedge such
risks; general economic conditions in the markets in which we
operate, including financial market conditions; our ability to
successfully integrate Cegedim’s Customer Relationship Management
and Strategic Data businesses; and the other factors set forth in
the “Risk Factors” section of our Annual Report on Form 10-K for
the period ending December 31, 2014, on file with the SEC, and any
subsequent SEC filings. We undertake no obligation to publicly
update any forward-looking statements whether as a result of new
information, future developments or otherwise.
IMSFIN
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150805006706/en/
IMS HealthInvestor RelationsTom Kinsley,
+1-203-448-4691tkinsley@imshealth.comorMedia RelationsTor
Constantino, +1-484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Sep 2023 to Sep 2024